AUTHORS: Kambiz Hassan et al
Ann Thorac Cardiovasc Surg. 2022 Jan
OBJECTIVE To analyze the results of hemoadsorption in patients with cardiac surgery to thoracic aortic surgery, who had been loaded beforehand with either Factor Xa inhibitor rivaroxaban or P2Y12 receptor antagonist ticagrelor.
METHODS We investigated 21 of 171 consecutive patients (median age 71 [interquartile range 62, 76] years) who underwent emergency cardiac operations for acute type A aortic dissection between 2014 and 2020. These patients were pretreated with rivaroxaban (n = 9) or ticagrelor (n = 12). In ten of 21 cases (since 2017), we installed a hemoadsorber into the heart-lung machine and compared the results to eleven patients done without hemoadsorber before that time.
RESULTS The operation time was significantly shorter in the adsorber group (286 B1 40 min vs. 348 B1 79 min; p = 0.045). The postoperative 24-hour drainage volume was significantly lower after adsorption